By a News Reporter-Staff News Editor at Biotech Week -- ICON plc, (NASDAQ: ICLR) a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, announced that Dr. Steve Cutler has been appointed to the newly created position of Chief Operating Officer (COO), ICON plc (see also ICON).
Dr. Cutler joined ICON in November 2011 as Group President, Clinical Research Services. In his new role as COO, Dr. Cutler has responsibility for all of ICON's operational units, covering Early Phase, Clinical, Laboratories, Commercialisation and Outcomes and DOCS FSP & resourcing. Dr Cutler will also take responsibility for ICON's sales and marketing and strategic alliance teams.
Within Dr. Cutler's team, Dr. Nuala Murphy has been appointed President, ICON Clinical Services and Mr. Jim Miskel has been appointed Executive Vice President & General Manager, ICON Laboratory Services.
Dr. Murphy joined ICON in 2012 as Executive Vice President, Global Clinical Operations and Data Management, bringing to ICON over 22 years' experience within the pharmaceutical and CRO industries. In her new role, Dr. Murphy will oversee ICON's global clinical services, comprising clinical and data operations, study start-up, project management, clinical risk management, technology services and clinical scientific operations.
Mr. Miskel joined ICON in November 2013 and will lead ICON's newly combined Central and Bioanalytical laboratories group. He brings a wealth of laboratory and pharmaceutical industry experience to ICON, having previously held senior positions with Harlan Laboratories, MDS Pharma Services, Wyeth Pharmaceuticals and McKinsey & Company.
Commenting on the appointments, Ciaran Murray, Chief Executive Officer, ICON plc, said: "We continually review our structure to ensure that as the market evolves, our organisation can continue to provide customers with innovative and integrated solutions across our various service lines and business units. Bringing all operational units under Steve's leadership will allow us to further enhance the support we can offer to our customers' development programs. I would like to congratulate Steve, Nuala and Jim on their new roles and wish them every success in the future." About ICON plc ICON plc is a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. The Company specialises in the strategic development, management and analysis of programs that support clinical development - from compound selection to Phase I-IV clinical studies. ICON currently has approximately 10,300 employees, operating from 77 locations in 38 countries.
Keywords for this news article include: ICON.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC